Last Findings on Dual Inhibitors of Abl and Src Tyrosine-Kinases

By  

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 2, 2007-02 ,pp. : 191-201

Bentham Science Publishers

Access to resources Recommend Favorite

Novel dual Src/Abl inhibitors for hematologic and solid malignancies

By Schenone Silvia   Brullo Chiara   Musumeci Francesca   Botta Maurizio  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 8, 2010-08 ,pp. : 931-945

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of Tyrosine Kinases in the Treatment of Psoriasis

By  

Current Pharmaceutical Design, Vol. 6, Iss. 9, 2000-06 ,pp. : 933-942

Bentham Science Publishers

Access to resources Recommend Favorite

Tyrosine Kinases as Therapeutic Targets in BCR-ABL Negative Chronic Myeloproliferative Disorders

By  

Current Drug Targets, Vol. 8, Iss. 2, 2007-02 ,pp. : 205-216

Bentham Science Publishers

Access to resources Recommend Favorite

Efficient Optimization Strategy for Marginal Hits Active Against abl Tyrosine Kinases

By  

Current Drug Discovery Technologies, Vol. 1, Iss. 3, 2004-10 ,pp. : 201-210

Bentham Science Publishers

Access to resources Recommend Favorite